Stocklytics Platform
Asset logo for symbol AADI
Aadi Bioscience
AADI64
$2.30arrow_drop_up1.31%$0.03
Penny Stock
Asset logo for symbol AADI
AADI64

$2.30

arrow_drop_up1.31%

Performance History

Chart placeholder
Key Stats
Open$2.30
Prev. Close$2.28
EPS-2.28
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$56.68M
PE Ratio-
LOWHIGH
Day Range2.25
2.36
52 Week Range1.21
5.70
Ratios
EPS-2.28

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Aadi Bioscience (AADI)

Aadi Bioscience, Inc. (AADI) is a biotechnology company focused on developing precision therapies for cancer treatment. The company's primary focus is on developing targeted therapies that exploit specific genetic mutations in cancer cells. AADI's approach is based on the principle that by targeting specific genetic mutations, they can develop therapies that have a higher likelihood of success and fewer side effects than traditional chemotherapy or radiation therapy.
AADI's stock price history has shown significant volatility over the past year. The stock price has ranged from a low of $10.56 to a high of $87.34. This volatility is not surprising given the company's early-stage status and the inherent uncertainty associated with drug development. However, AADI has received positive news recently, with the announcement of promising results from a Phase 2 clinical trial for their lead therapy. This news has helped to boost investor confidence and drive the stock price higher.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Scott M. Giacobello CPA
Headquarters
Pacific Palisades
Employees
89
Exchange
NASDAQ
add Aadi Bioscience to watchlist

Keep an eye on Aadi Bioscience

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Aadi Bioscience's (AADI) price per share?

The current price per share for Aadi Bioscience (AADI) is $2.3. The stock has seen a price change of $0.03 recently, indicating a 1.32% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Aadi Bioscience (AADI)?

For Aadi Bioscience (AADI), the 52-week high is $5.7, which is 147.83% from the current price. The 52-week low is $1.21, the current price is 90.08% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Aadi Bioscience (AADI) a growth stock?

Aadi Bioscience (AADI) has shown an average price growth of -3.66% over the past three years. It has received a score of 3 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Aadi Bioscience as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Aadi Bioscience (AADI) stock price performance year to date (YTD)?

As of the latest data, Aadi Bioscience (AADI) has a year-to-date price change of 12.2%. Over the past month, the stock has experienced a price change of 19.17%. Over the last three months, the change has been 45.57%. Over the past six months, the figure is 26.37%.
help

Is Aadi Bioscience (AADI) a profitable company?

Aadi Bioscience (AADI) has a net income of -$65.76M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 88.47% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -149.4% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $24.35M, with a revenue growth rate of 60.06%, providing insight into the company's sales performance and growth. The gross profit is $21.54M. Operating income is noted at -$71.93M. Furthermore, the EBITDA is -$63.4M.
help

What is the market capitalization of Aadi Bioscience (AADI)?

Aadi Bioscience (AADI) has a market capitalization of $56.69M. The average daily trading volume is 2.3, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level